Seminars in Liver Disease

Papers
(The H4-Index of Seminars in Liver Disease is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-10-01 to 2025-10-01.)
ArticleCitations
Hepatic Extracellular Matrix and Its Role in the Regulation of Liver Phenotype76
Tight Junction Proteins as Therapeutic Targets to Treat Liver Fibrosis and Hepatocellular Carcinoma40
Critical Care Management of Acute-on-Chronic Liver Failure: Certainties and Unknowns32
Liver Immunology, Immunotherapy, and Liver Cancers: Time for a Rethink?32
A Precision Medicine Guided Approach to the Utilization of Biomarkers in MASLD30
Tailored Model of Care for Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease26
Patient-Reported Outcomes in Metabolic Dysfunction-Associated Steatotic Liver Disease25
HBV Biomarkers and Their Role in Guiding Treatment Decisions23
Genetic and Epigenetic Basis of Drug-Induced Liver Injury22
Emerging Targets for the Treatment of Primary Sclerosing Cholangitis21
Genetic Contributions to Biliary Atresia: A Developmental Cholangiopathy18
Growth Hormone Signaling in Liver Diseases: Therapeutic Potentials and Controversies17
Mice Engrafted with Human Liver Cells16
Physiomimetic In Vitro Human Models for Viral Infection in the Liver15
Alcohol Plus Additional Risk Factors: Rodent Model of Liver Injury14
0.58513617515564